top of page
  • KBM

USP Considerations During Pandemic

On 11 April 2020, the United States Pharmacopeia (USP) issued guidance regarding operational considerations during the COVID-19 pandemic. These instructions include assignment of beyond use dates, certifications, and cleaning/disinfecting. The Joint Commission (TJC) has issued declared that "(o)rganizations may utilize these guidelines and remain in compliance with Joint Commission standards until the state of emergency has been lifted at the regional, state or national level."


https://go.usp.org/l/323321/2020-04-11/345w2b


https://www.jointcommission.org/resources/news-and-multimedia/blogs/on-infection-prevention-control/2020/04/29/sterile-compounding-considerations-during-covid-19/


4 views0 comments

Recent Posts

See All

This article begins to highlight the need for effective contract performance documentation and evaluation. You must place specific, measurable, attainable, relevant, and timely (SMART) key performanc

Post: Blog2_Post
bottom of page